← Eichor
Condition: Chronic Liver Injury Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Chronic Liver Injury

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompens
NA · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06431919F573 for Injection for the Treatment of Liver Injury/Failure
Phase 2 · 10 location(s) · Beijing Continent Pharmaceutical Co, Ltd. · NCT05689645Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient Elastograp
Phase N/A · 1 location(s) · Xinhua Hospital, Shanghai Jiao Tong University School of Med · NCT07128108Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive Immunoglobulin G
Phase N/A · 6 location(s) · Hannover Medical School · NCT05810480CytOSorb TreatMent Of Critically Ill PatientS Registry
Phase N/A · 28 location(s) · CytoSorbents, Inc · NCT05146336SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury
Phase N/A · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06173947MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT03175471
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.